Results

Total Results: 1,887 records

Showing results for "testing".

201. Cell-Free-Dna-Final-App-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
     January 01, 2025 - included CT, ultrasound, blood testing, hepatitis testing, urine testing, ECG, mammogram, Pap smear) … Radiation exposure from PET-CT as potential harm of evaluation and additional testing. … Unclear Yes Unclear None NR Cancer patients had testing prior to any treatment. … NR Testing was performed prior to cancer treatment. … NR Testing occurred prior to any treatment.

202. Data Points #15: Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/dcis-prognostic-tests/research

203. Disposition of Comments for Imaging Tests for the Staging of Colorectal Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_disposition-comments.pdf
     November 20, 2014 - This standard helps imaging facilities conduct quality testing and monitoring of X-ray equipment used

204. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
     January 01, 2013 - ; however, the evidence for the potential harms associated with testing or test-associated treatment … What are the adverse effects or harms associated with testing using newer and/or older markers of … Studies did not attribute these deaths to either testing or any treatment. … The major burden would be additional testing as per protocol. … A randomized trial of iron deficiency testing strategies in hemodialysis patients.

205. Effectiveness of Noninvasive Diagnostic Tests for Breast Abnormalities Appendices (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_appendixes.pdf
     May 23, 2005 - This is because meta-regression is hypothesis generating, not hypothesis testing.

206. Evidence Summary_Pharmacologic and Nonpharmacologic Treatments for PTSD: An Update of the PTSD-Repository Evidence Base (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharma-ptsd-update-summary.pdf
     November 01, 2020 - expanding specific elements of the ROB criteria that may affect studies of PTSD more particularly, pilot testing … Our exploration and pilot testing of an expanded ROB assessment system emphasized more detailed assessment

207. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-risk-bias.ppt
     June 01, 2012 - don’t know status” are excluded and do not have their disease status verified (no reference standard testing … Relatives who are DECEASED are excluded from having any verification undertaken (no reference standard testing … Relatives who are UNABLE TO PARTICIPATE in interviews or further clinical testing are excluded from having … any verification method (no reference standard testing).

208. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-risk-bias.ppt
     June 01, 2012 - don’t know status” are excluded and do not have their disease status verified (no reference standard testing … Relatives who are DECEASED are excluded from having any verification undertaken (no reference standard testing … Relatives who are UNABLE TO PARTICIPATE in interviews or further clinical testing are excluded from having … any verification method (no reference standard testing).

209. Colorectal-Cancer-Protocol_130520 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
     May 20, 2013 - Services Task Force currently recommends screening for colorectal cancer using fecal occult blood testing … Staging Systems Once the diagnosis has been established, patients with colorectal cancer undergo testing … The differences in the testing protocols associated with different imaging modalities can affect their … Intermediate outcomes such as test performance and harms of testing can be measured immediately after … For questions about the impact of testing on patient-oriented clinical outcomes, comparative studies

210. Disposition of Comments Report for The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-197-fractional-exhaled-nitric-oxide-disposition-comments.pdf
     December 20, 2017 - TEP #2 Methods Methods were explicit and well described; i can not comment on the statistical testing … A summary of these and their relation to sensitivity/specificity of FeNO testing could be developed … We added sentences about factors that may affect FeNO testing in the future research needs. … In the example, a cutoff 20 ppb, any testing value above is positive, and below is negative. … KQ 1e: In children ages 0-4 years with recurrent wheezing, how accurate is FeNO testing in predicting

211. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
     January 01, 2011 - stems from inadequate diet and absorption, procedure-related iron losses from repeated laboratory testing … What are the adverse effects or harms associated with testing using newer and/or older markers of iron … o Adverse effects or harms associated with testing and associated treatments (e.g., test- related anxiety … iron -Transferrin saturation -Iron-binding capacity -Ferritin Adverse events related to lab testing … A randomized trial of iron deficiency testing strategies in hemodialysis patients.

212. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/undescended-testicle_research-protocol.pdf
     September 02, 2011 - Treatment decisions may be guided by results of hormonal stimulation testing and/or imaging. … The purpose of hormonal stimulation testing is to determine if viable testicular tissue is present. … In theory, absence of a testosterone increase in response to hormonal stimulation testing or inability … developmental abnormalities (including intersexuality) that can be life threatening, warranting specific testing … 1b In male children with bilateral, nonpalpable testes, does the use of hormonal stimulation testing

213. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0311_06-17-2008.pdf
     January 01, 2008 - troponin levels regardless of their renal status, which can result in unnecessary hospitalizations and testing

214. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0440_06-01-2011.pdf
     January 01, 2011 - treatment); more frequent screening with the potential for false positive results and further downstream testing

215. Imaging Tests To Check for Kidney Stones in the Emergency Department (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-stone-imaging_consumer.pdf
     July 01, 2016 - Imaging Tests To Check for Kidney Stones in the Emergency Department Imaging Tests To Check for Kidney Stones in the Emergency Department Checking for Kidney Stones in the Emergency Department First, the emergency doctor will give you medicine to help stop your pain. The medicine may be given by mouth. Or…

216. Methods Guide for Medical Test Reviews Chapter 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-introduction_methods.pdf
     July 01, 2012 - Methods Guide for Medical Test Reviews Chapter 1 1-1 Chapter 1 Introduction to the Methods Guide for Medical Test Reviews David B. Matchar, M.D., FACP, FAHA; Duke-NUS Graduate Medical School Singapore; Duke University Medical Center, Durham, NC Abstract Evaluation of medical tests presents cha…

217. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Biogen (Cambridge, MA) has advanced this candidate drug to phase III testing, despite initial analysis … of intermediate doses used in phase I testing showing no clinical efficacy. … Testing takes about 10 minutes, and the system generates rapid, easily interpreted assessments of patients

218. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-options-summarizing.ppt
     June 01, 2012 - Studies have shown that PSA testing is prone to misclassification error. … These include when a new method of testing is an improved version of the usually applied test.

219. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-options-summarizing.ppt
     June 01, 2012 - Studies have shown that PSA testing is prone to misclassification error. … These include when a new method of testing is an improved version of the usually applied test.

220. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-intro.ppt
     June 01, 2012 - A causal chain diagram can be used to illustrate the steps from the testing phase to the point that a